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Gap detection or gap pre-pulse inhibition of the acoustic startle (GPIAS) has been
successfully used in rat and guinea pig models of tinnitus, yet this system has been
proven to have low efficacy in CBA mice, with low basal GPIAS and subtle tinnitus-
like effects. Here, we tested five mouse strains (CBA, BalbC, CD-1, C57BL/6 and
129sv) for pre-pulse inhibition (PPI) and gap detection with varying interstimulus intervals
(ISI) and found that mice from a CBA genetic background had the poorest capacities
of suppressing the startle response in the presence of a pre-pulse or a gap. CD-1
mice displayed variable responses throughout all ISI. Interestingly, C57BL/6, 129sv and
BalbC showed efficient suppression with either pre-pulses or gaps with shorter ISI. The
glutamate aspartate transporter (GLAST) is expressed in support cells from the cochlea
and buffers the excess of glutamate. We hypothesized that loss of GLAST function
could sensitize the ear to tinnitus-inducing agents, such as salicylate. Using shorter
ISI to obtain a greater dynamic range to assess tinnitus-like effects, we found that
disruption of gap detection by salicylate was exacerbated across various intensities
of a 32-kHz narrow band noise gap carrier in GLAST knockout (KO) mice when
compared to their wild-type (WT) littermates. Auditory brainstem responses (ABR)
and distortion-product otoacoustic emission (DPOAE) were performed to evaluate the
effects on hearing functions. Salicylate caused greater auditory threshold shifts (near
15 dB) in GLAST KO mice than in WT mice across all tested frequencies, despite
similarly reduced DPOAE. Despite these changes, inhibition using broad-band gap
carriers and 32 kHz pre-pulses were not affected. Our study suggests that GLAST
deficiency could become a useful experimental model to decipher the mechanisms
underlying drug-induced tinnitus. Future studies addressing the neurological correlates
of tinnitus in this model could provide additional insights into the mechanisms of
tinnitus.
Keywords: hearing loss, salicylate, tinnitus, gap detection, pre-pulse inhibition, startle response, mouse, disease
models
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INTRODUCTION
Tinnitus remains an untreatable condition frequently associated
with stress, anxiety or depression (Baguley et al., 2013),
and affects 10–15% of the population. In spite of increasing
attention towards the understanding and treatment of tinnitus,
experimental efforts in the field remain relatively limited in
comparison to the numerous clinical reports (Cederroth et al.,
2013). Experimentally, the induction of tinnitus is achieved
through noise overexposure or the administration of ototoxic
drugs (e.g., salicylate, quinine or cisplatin; Stolzberg et al., 2012;
von der Behrens, 2014).
Advances in the field of tinnitus have been made due to
the development of behavioral methods to objectively assess the
perception of non-existing sounds. Gap pre-pulse inhibition of
the acoustic startle reflex (GPIAS), validated in a rat model
of tinnitus using the operant conditioning paradigm (Turner
et al., 2006; Turner and Parrish, 2008), resembles pre-pulse
inhibition of the acoustic startle reflex (PPI or PPIAS), whereby a
reduction in the response to an intense stimulus is observed when
preceded by a subthreshold intensity pre-pulse (Ison et al., 1973;
Graham, 1975). Animal models or humans with schizophrenia
or bipolarity disorders have deficits in inhibiting the startle
reflex with a pre-pulse as a consequence of a dysfunction in
the sensorimotor gating mechanism (Braff et al., 1978; DelPezzo
and Hoffman, 1980). In contrast to PPI, which uses a low-
intensity pre-pulse to inhibit the startle reflex, GPIAS presents
a silent gap embedded in a continuous carrier noise. Despite
startle suppression being calculated similarly for both GPIAS and
PPI, these use different neural pathways to regulate inhibition.
Lesion studies have shown that the auditory cortex regulates
GPIAS but not PPI (Bowen et al., 2003). When used in the
context of tinnitus, as an animal’s tinnitus closely matches the
background noise, the startle reflex is less suppressed by the pre-
pulse gap because tinnitus interferes with the optimal inhibition
of the startle reflex mediated by the gap. As a consequence,
affected animals display greater startle response (meaning less
inhibited) than in the absence of tinnitus. The use of GPIAS
for the assessment of tinnitus has been supported by additional
neuronal correlates of tinnitus such as increased spontaneous
firing rates in the dorsal cochlear nucleus (DCN; Li et al., 2013),
hyperactivity in the inferior colliculus (Holt et al., 2010) and
remapping of the auditory cortex (Engineer et al., 2011).
CBAmice have been conventionally used in auditory research
for their excellent hearing abilities. In contrast, C57BL/6, in
which mutant strains have been traditionally developed, display
age-related hearing loss due to a point mutation on the Cdh23
gene (Ohlemiller and Gagnon, 2004) and thus have been less
accepted in the auditory field. However, in the absence of
tinnitus, suppression of the startle response with the presence
of a gap in narrow band carriers remains highly inefficient
in CBA mice (10–50%; Middleton et al., 2011; Llano et al.,
2012; Hickox and Liberman, 2014) when compared to that in
rats (40–60%; Turner et al., 2006; Turner and Parrish, 2008;
Engineer et al., 2011; Su et al., 2012; Yi et al., 2016), consequently
offering a small dynamic range to distinguish tinnitus-like effects.
Thus, improving the basal suppression of gap detection in mice
would increase the confidence window for detecting tinnitus.
Curiously, mice appear to be resistant to developing tinnitus,
as only 20–50% of the mice that are exposed to noise display
behavioral evidence of tinnitus (Middleton et al., 2011; Li et al.,
2013), compared to 70–75% of that in rats (Wang et al., 2009;
Zhang et al., 2011; Ruttiger et al., 2013). These observations
are consistent with the notion that mice are more resilient
than guinea pigs to drug-induced hearing loss by, for instance,
aminoglycoside antibiotics or the anti-cancer drug cisplatin
(Poirrier et al., 2010). Overall, a smaller number of mice display
noise-induced changes in GPIAS than do rats, and this species
appears more resistant to drug-induced hearing loss than are
guinea pigs.
The glutamate aspartate transporter (GLAST) appears as
a potential candidate to explain such differences. GLAST
belongs to the family of glutamate transporters that stabilize
the extracellular environment and maintain cell-to-cell
communication. GLAST, but not GLT1, has been identified
in the hearing organ, the cochlea (Jin et al., 2003). GLAST is
present in the inner phalangeal cells (IPCs) that surround the
sensory inner hair cells (IHCs) and afferent neuron synapse (Ruel
et al., 2007), where it pumps back excessive glutamate released
by sensory cells (Glowatzki et al., 2006) during noise exposure
(Hakuba et al., 2000; Chen et al., 2010). As a consequence,
mice lacking GLAST show greater hearing threshold shifts
and synaptic damage than do wild-type (WT) mice after noise
exposure (Hakuba et al., 2000; Chen et al., 2010). GLAST is
hardly detectable in the cochlea of rats or guinea pigs and is
abundant in the mouse cochlea (Jin et al., 2003). This is why
we hypothesized that GLAST abundance in the murine cochlea
could underlie the resilience of mice to inner ear insults by drugs,
and potentially tinnitus.
Research on tinnitus would benefit from the use of mice,
whose species offers facilitated genetic manipulations for
understanding the mechanisms that are related to this auditory
disorder. In the present study, we address the limitations of
using mice by: (i) increasing the dynamic range of startle
suppression in the presence of a gap; and (ii) identifying a protein
whose disruption exacerbates gap detection deficits induced by
salicylate. By combining these two advances, we propose a new
mouse model for investigating tinnitus.
MATERIALS AND METHODS
Experimental Animals
Experimental procedures on animals performed at the
Karolinska Institutet were in accordance with the guidelines
and regulations set out by the University and Stockholm’s
Norra Djurförsöksetiska Nämnd. Experiments performed at
the Rockefeller University were approved by the Institutional
Animal Care and Use Committee of The Rockefeller University.
GLAST knockout (KO) mice on a C57BL/6 background (Watase
et al., 1998) and the other listed strains (from Charles Rivers)
were maintained at 19–21◦C in a 50%–50% light-dark cycle.
GLAST KO mice and their WT littermates were
obtained from heterozygous crosses. We observed a non-
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mendelian distribution in the progeny of crosses between
heterozygous KO mice (n = 145): 28% WT animals, 61%
heterozygous KO animals, and only 10% homozygous KO
animals. When crossing male homozygotes with female
heterozygotes, we obtained 80% heterozygous and 20%
homozygous KO animals among the progeny. In addition,
homozygous females appeared highly anxious and displayed
pup-killing behavior. Only male mice between 2 and 4
months of age were used in this study. Baseline auditory
thresholds of GLAST KO mice measured by auditory
brainstem responses (ABR) within this age range were
similar to those of WT littermates (8 kHz = 35.71 ± 2;
16 kHz = 19.29 ± 0.7; 32 kHz = 29.64 ± 1.7; KO:
8 kHz = 38 ± 1.7; 16 kHz = 21 ± 1; 32 kHz = 32 ± 1.33;
p= 0.97 by a 2-way ANOVA).
The animals had free access to water and food. They
were injected daily with intraperitoneal (i.p.) sodium salicylate
(Sigma, S3007) at 300 mg/kg diluted in 0.9% NaCl for three
consecutive days. Hearing threshold measures and behavior
tests were performed 2 h after the last injection, as previously
described (Guitton et al., 2003).
Auditory Brainstem Responses
Mice were anesthetized with 80 mg/kg ketamine and 12 mg/kg
xylazine for measurements of ABR. The positive needle
electrode was inserted subdermally at the vertex, the negative
electrode was placed beneath the pinna of the left ear, and
the ground electrode was located near the tail. ABR were
evoked by tone bursts of 8, 16 and 32 kHz, produced by a
closed-field electrostatic speaker connected to a driver (EC-1
and ED-1, Tucker-Davis Technologies). The 5-ms signals
were presented 33.3 times per second; their 0.5-ms onsets
and offsets were tapered with a squared cosine function.
The speaker’s audio output was transmitted into the ear
through a custom acoustic coupler. Sound pressure levels
were measured with a calibrated microphone and preamplifier,
connected to a conditioning amplifier (4939-A-011 and 2690-
A-0S1, Brüel and Kjær). The response was amplified 10,000×
and bandpass filtered at 0.3–3 kHz (P55, Natus Neurology
Inc.). The amplified response was then digitally sampled
at 10-µs intervals with a data acquisition device (USB-
6210, National Instruments), controlled by custom software
(LabVIEW 2010, National Instruments). The responses to 1000
bursts were averaged at each intensity level to determine
the threshold; the threshold is defined as the lowest level
at which a response peak is distinctly and reproducibly
present. For each frequency, the sound pressure level was
decreased from 100 dB SPL in 5 dB steps, until the threshold
was reached and confirmed with one replicate measure.
Threshold shifts were measured against individual’s baseline
values.
Distortion-Product Otoacoustic Emissions
Distortion-product otoacoustic emissions were elicited with
an acoustic assembly, consisting of two electrostatic speakers
(EC-1, Tucker-Davis Technologies), to generate primary tones
and a miniature microphone (EK-23103, Knowles) to measure
ear-canal sound pressure. The speakers and the microphone
were both calibrated with the calibration microphone described
above. The 2f 1 − f 2 distortion product was measured
with f 1 = 6–24 kHz, f 2/f 1 = 1.25 and the stimulus
levels L1 = L2 = 75 dB SPL. The acoustic signal was
amplified by a preamplifier (ER-10B+, Etymotic Research),
and the sound pressure measured in the ear canal was
digitally sampled at 10-µs intervals with the data acquisition
system described above. Each frequency pair was presented
for 1 s. After computing fast Fourier transforms and averaging
them over 10 consecutive traces, we determined for each
frequency pair the amplitudes of the 2f 1 − f 2 distortion
product and of the noise floor measured at ±100 Hz from
2f 1 − f 2; this procedure required 17 s of data acquisition and
processing.
Testing of the Interstimulus Interval
Interstimulus intervals (ISI) were tested using the SR-Lab startle
response system from San Diego Instruments as previously
described withminor modifications (Lowry et al., 2013). Animals
were acclimated to the procedure on day 1, and were tested for
PPI on day 2 and GPIAS on day 5. Background sound level
(unfiltered white noise) was 65 dB SPL for PPI sessions, with pre-
pulses of 75 dB SPL. For GPIAS, carrier level was 80 dB SPL and
silent gaps (absence of stimulus) went down to the noise floor
of the SR-Lab chamber. Startle pulses were presented at 115 dB
SPL. Trials varied pseudo-randomly in their ISI by 10 ms, from
150 to 0ms. Ten trials per ISI were tested. Inter-trial time interval
varied randomly from 8 to 15 ms. Twenty startle-only trials were
presented before the session, and five startle-only trials at the end
in order to assess habituation. Onewhole session of PPI or GPIAS
lasted 1 h.
Tinnitus Evaluation by the Gap Detection
Method
To test frequency-specific gap detection deficits, we developed
a custom-made set-up. Tests were performed in a sound-
attenuating chamber (ENV-022S, Med Associates, Inc.). whose
noise floor was 55 ± 0.5 dB SPL. In the case of PPI tests, which
were used to verify the normal sensorimotor gating, white noise
was generated by a function generator (DS340, Stanford Research
Systems) and filtered (Wavetek 852 Dual HI/LO Variable Analog
Filter, Butterworth filtered, 48 dB/octave roll-off) to 1 kHz-wide
narrowband noise centered at a given frequency or broadband
noise (BBN) and presented at a given sound intensity (60, 65, 70,
75, 80 dB SPL) in a silent environment for a duration of 50 ms
through a speaker (NX-6, Power Acoustik) positioned in front of
the animal. To startle an animal, a 20-ms white noise startle pulse
of 115 dB SPL was delivered from a second speaker positioned
above the animal, 70 ms after the pre-pulse. Calibration was done
using the microphone, preamplifier and conditioning amplifier
mentioned above.
For the gap detection tests that were used to evaluate tinnitus
perception, the same set-up was used. The gap carrier was filtered
as above into a broadband or 1 kHz-wide narrowband noise
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centered at a given frequency and presented at a given sound
intensity (60, 65, 70, 75, 80 dB SPL). A relay switch was used to
silence the noise for 50 ms, a gap with 0.1 ms rise and fall times
(RT/FT), which was followed 15 ms later by a 20-ms white noise
startle pulse of 115 dB SPL. The startle response was captured
through an electromagnetic coil, bandpass filtered at 3–100 Hz
and amplified 10× (P55, Natus Neurology Inc.). Gap detection
or PPI was quantified as the percentage decrease in the peak
amplitude of the startle response, when a warning gap or pre-
pulse preceded the startling noise in comparison to the amplitude
when no gap or pre-pulse was present [(1 − the ratio) × 100]
(Engineer et al., 2011), using a similar representation as used
in PPI studies (greater suppression of the startle reflex closer
to 100%). The more tinnitus fills the gap, the less inhibition of
the startle is observed. Only naïve animals were used in this
study.
Experimental Procedure for the Screening of the
Putative Tinnitus Frequency
This procedure was performed on a small group of animals
(n = 3) to identify the putative tinnitus frequency at which a
deeper analysis could be performed with a greater number of
animals (see below). Here, PPI was not performed in order to
avoid excessive habituation to the startle stimulus.
In order to acclimatize the animals to the testing procedure,
a 30-min preliminary test was performed on day 1. On the
following day (day 2), the experiment comprised a session of
three consecutive blocks.
Block 1
The first block started with a 5-min acclimatization to silence,
followed by 20 startle pulses; each of the pulses was 20 ms in
duration and at 115 dB SPL. The time between each trial was
random and varied between 8 and 12 s.
Block 2
The second block consisted in testing gap detection at various
carrier frequencies (BBN, 8, 10, 12, 16, 20, 24, 32-kHz) of 80 dB
SPL with 20 trials per frequency, with or without silent gaps
(50 ms). Each frequency was tested sequentially with 20 trials.
Each trial was performed with 20-ms startle pulses and an ISI of
15 ms.
Block 3
The final block comprised five trials only with startle pulses to
be compared with those of the first block to assess habituation.
A total of 185 trials was presented in approximately 40 min.
One day after the testing (day 3), animals were treated
with salicylate daily for 2 days and tested on the third day of
administration (day 5) with the same procedure.
Experimental Procedure for the Validation of the
Putative Tinnitus Frequency
This procedure was performed to validate the findings from the
frequency screening performed above. In order to acclimatize the
animals to the testing procedure, a 30-min preliminary test was
performed on day 1. On the following day (day 2), the experiment
comprised a session of four consecutive blocks.
Block 1
The first block started with a 5-min acclimation to silence,
followed by 20 startle pulses; each of the pulses was 20 ms in
duration and at 115 dB SPL. The time between each trial was
random and between 8 and 12 s.
Block 2
A second block of stimuli consisted in testing PPI with 20 trials
with or without pre-pulses (50 ms), first consisting of a BBN of
75 dB SPL, and then consisting of a 32 kHz centered narrowband
noise of successive intensities of 60, 65, 70, 75 and 80 dB SPL in
a quiet background. Each trial was performed with 20-ms startle
pulses and an ISI of 70 ms.
Block 3
The third block consisted in testing gap detection with 20
trials, with or without silent gaps (50 ms), first embedded in a
broadband carrier noise at 75 dB SPL and then embedded in a
32-kHz centered narrowband noise of successive intensities of 60,
65, 70, 75 and 80 dB SPL. Each trial was performed with 20-ms
startle pulses and an ISI of 15 ms.
Block 4
The final block comprised five trials only with startle pulses to
be compared with those of the first block to assess habituation.
A total of 265 trials were presented in approximately 55 min.
One day after the testing (day 3), animals were treated
with salicylate daily for 2 days and tested on the third day of
administration (day 5) with the same procedure.
Quantitative Real Time-PCR
SybrGreen qRT-PCR assays from cochlear extracts were
performed as previously described (Meltser et al., 2014;
Vikhe Patil et al., 2015). A mean quantity was calculated
from triplicate PCR for each sample, and this quantity
was normalized with the geometric mean of the three
most stable genes out of six reference genes (tubulin β,
Tubb; glyceraldehyde-3-phosphate dehydrogenase, G3pdh;
transferring receptor 1, Trf1R; Tubulin α2, Tuba2; hypoxanthine
phosphoribosyltransferase, HPRT; and Cyclophilin B) selected
using the geNorm algorithm as described (Vandesompele et al.,
2002). Normalized quantities were averaged for three technical
replicates for each data point and represented as mean± SD. The
highest normalized relative quantity was arbitrarily designated
1.0. Fold changes were calculated from the quotient of means of
these normalized quantities and reported as± SEM. The primers
for eaat1 used are F: 5′-GGGAAGATGGGGATGCGAG-3′ and
R: 5′-GCCGAAGCACATGGAGAAG-3′.
Statistical Analysis
Two-way ANOVA and a Bonferroni post hoc were used for
statistical analysis (Prism version 4.0, GraphPad software).
Differences were considered significant if P < 0.05. Animals that
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failed to respond to the startle (any peak-to-peak response above
noise floor was considered a startle) or failed to inhibit the startle
in the presence of a pre-pulse before salicylate treatment (any
decrease in startle amplitude during pre-pulse trials vs. startle
only trials) were excluded from the analysis (near 5%). When
performing PPI tests using a pre-pulse of 80 dB SPL, nearly
10% of the pre-pulses elicited a startle, which then completely
suppressed the startle response. The greater the intensity of
the pre-pulse, more efficient was the inhibition of the startle
response. As a consequence, trials in which the 80 dB pre-pulse
induced a startle response before the startle pulse (10% of the
80 dB pre-pulse trials) were excluded from the analysis.
RESULTS
Shorter Interstimulus Interval Improves
GPIAS in Specific Mouse Strains
When developing a custom-made gap detection set-up, we found
that the ability of C57BL/6 mice to inhibit the startle response
in the presence of a gap was almost null when using similar
settings to those used for PPI (duration of the pre-pulse: 50 ms;
ISI: 70 ms; startle duration: 20 ms; startle intensity: 115 dB).
This particular paradigm only reduced the startle response by
20% (data not shown). We found that GPIAS was particularly
sensitive to modifications of the ISI. We observed that in both
C57BL/6 and 129sv mice, unlike for PPI, the shorter the ISI,
the greater the inhibition of startle response, achieving up to
80% in C57BL/6 and 129sv mice (Figures 1B,C). Measures of
the startle amplitude before and after each PPIAS or GPIAS
session confirmed the lack of habituation during this test (data
not shown). While this pattern was present in CBA mice, it
did not exceed more than 50% at the lowest ISI, strongly
suggesting that the inhibition of the startle reflex in this strain
is not efficient (Figure 1D). This trend was not observed when
using other genetic backgrounds such as CD-1 and Balb-C mice
(Figures 1E,F). In Balb-C, PPI and GPIAS followed a similar
course over varying ISIs, and CD-1 had highly variable responses,
suggesting they would require additional acclimatization sessions
(as typically performed with rats) to obtain a more robust
reflex response. Overall, it is concluded that ISI is a critical
parameter for improving gap detection in C57BL/6 and 129sv
mice, and that shorter ISIs can be used to increase the basal
level of suppression of the startle response in these strains in
order to provide greater dynamic range to detect deficits in gap
detection.
Salicylate Causes Severe Gap Detection
Deficits in GLAST KO Mice
The basal level of startle suppression in the presence of a gap
was further improved using Longenecker and Galazyuk (2012)
recommendations by: (i) adjusting speaker non-linearity by
calibrating the intensity output for each filtered narrowband
noise; (ii) suppressing echo and reverberation by covering the
interior walls with sound-insulating foam; and (iii) replacing the
acrylic animal restrainer with a non-resonating perforated plastic
pipette box. Because noise is effective in inducing tinnitus in
nearly 50% of animals, we used salicylate, which is the most
commonly used drug in animal models of tinnitus (Cazals, 2000;
von der Behrens, 2014). Salicylate has an advantage over noise
in that it has previously been used in humans to induce tinnitus
FIGURE 1 | Shorter interstimulus intervals (ISI) improves gap-mediated suppression of the startle response. (A) Schematic model of the experiment. Male
C57BL/6 (B), 129sv (C), CBA (D), Balb/C (E) and CD-1 (F) male mice (2–4 months old) were exposed to pre-pulse inhibition of the acoustic startle reflex (PPIAS)
(black diamonds) and gap pre-pulse inhibition (PPI) of the acoustic startle (GPIAS; open circles) sequentially. ISI was modified by steps of 10 ms. Average startle
amplitudes before and after each paradigm were not affected. Data represent means ± SEM (n = 8).
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(3.9 g salicylate/day for 5 days; Mongan et al., 1973; McFadden
et al., 1984).
We screened various 1-kHz narrowband frequencies (from
8 to 32 kHz) in a small group of animals (n = 3) to identify
the putative tinnitus frequency, meaning the frequency at which
GPIAS would be most affected by salicylate treatment according
to a previous model (300 mg/kg/day for 3 days, Guitton et al.,
2003). We used a carrier noise of high intensity (80 dB SPL) to
maximize the inhibition of the startle by the gap and identify
the frequencies with the greatest changes. This initial screening
showed that bothWT and KOmice treated with salicylate exhibit
greater deficits in sensing the gap at 32 kHz (two-way ANOVA,
Genotype and Treatment Factor: F(7,64) = 6.108, p < 0.0001;
Frequency Factor: F(3,64) = 11.44, p< 0.0001, data not shown).
We next focused on the 32-kHz narrowband noise to perform
both GPIAS, using different carrier intensities, and PPI, using
increasing pre-pulse intensities. PPI was used as a control for
normal temporal processing or sensory motor gating. Before
salicylate administration, WT animals increasingly detected the
gap with increasing intensities of a narrowband carrier noise
centered at 32 kHz, inhibiting their startle reflexes up to 91%
(Figure 2A). After 3 days of salicylate administration, the ability
of WT mice to repress their startle reflexes decreased by 25% at
all carrier intensities tested (p < 0.0001 by a two-way ANOVA
with Bonferroni post hoc test, Treatment Factor, F(1,110) = 40.46,
p< 0.0001; Carrier Intensity Factor, F(4,110) = 35.36, p< 0.0001;
Figure 2A). Salicylate did not affect PPI with the exception of
the lowest intensity of pre-pulse tested, suggestive of hyperacusis
(p = 0.03 by a two-way ANOVA with Bonferroni post hoc test,
Treatment Factor, F(1,111) = 4.64, p= 0.0333; Pre-pulse Intensity
Factor, F(4,111) = 25.40, p < 0.0001; Figure 2B). The overall gap
detection deficits, although significant, appeared to be relatively
small.
Before salicylate treatment, GLAST KO mice displayed
GPIAS as efficiently as WT mice (two-way ANOVA,
Genotype Factor: F(1,79) = 0.4351, p = 0.5114; Carrier
Intensity Factor: F(4,79) = 57.0, p < 0.0001). However,
after salicylate treatment, the ability of GLAST KO mice to
detect the gap was severely impaired throughout all carrier
intensities tested (two-way ANOVA with Bonferroni post
hoc test, Treatment Factor: F(1,89) = 117.5, p < 0.0001;
Carrier Intensity Factor: F(4,89) = 16.02, p < 0.0001;
Figure 2C). Although PPIAS at 32 kHz appeared to be
lower in GLAST KO mice than in WT mice (two-way
ANOVA, Genotype Factor: F(1,105) = 17.19, p < 0.0001;
Pre-pulse Intensity Factor: F(4,105) = 27.54, p < 0.0001),
it was not affected by salicylate administration (two-way
ANOVA, Treatment Factor: F(1,105) = 0.2299, p = 0.6326;
Pre-pulse Intensity Factor: F(4,105) = 15.72, p < 0.0001,
Figure 2D), suggesting that the disruption of gap detection
is more likely a tinnitus effect rather than a deficit in
temporal processing or in auditory sensitivity (hyperacusis-
like phenomenon).
To confirm the frequency-specific effects on GPIAS observed
after the treatment with salicylate, we used a BBN Gap or
pre-pulse (BBN PPI) at 75 dB SPL, and next verified whether
inhibition of the startle response was affected before and
FIGURE 2 | Glutamate aspartate transporter (GLAST) deficiency
facilitates the induction of tinnitus by salicylate. GPIAS in wild-type (WT)
(A) and GLAST knockout (KO) (C) mice before (dark) and 2 h after the last
salicylate (SS) administration (purple) using a 32-kHz narrowband carrier noise
presented with a 5 dB step increase in intensity. PPIAS in WT (B) and GLAST
KO (D) mice before (dark) and after (purple) salicylate treatment using a
32-kHz narrowband pre-pulse presented with a 5 dB step increase in
intensity. Normal gap (E) and pre-pulse sensing (F) in WT and GLAST KO
mice before (white) and after (black) the injection of SS using a broadband
noise (BBN) at 75 dB SPL carrying a silent gap (GPIAS session) or a 75 dB
SPL broadband pre-pulse presented in a silent environment (PPI session).
Pre-treatment values are shown in dark, and SS values are shown in filled
symbols in purple. WT mice are shown with circles and GLAST KO mice are
shown with diamonds. Data represent means ± SEM (n = 8–14). ∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001, by a two-way ANOVA with
post hoc Bonferroni test.
after salicylate administration in both WT and GLAST KO
mice. GPIAS in a BBN carrier was equally efficient before or
after salicylate treatment in both genotypes (two-way ANOVA,
Genotype Factor: F(1,40) = 0.7098, p= 0.4045; Treatment Factor:
F(1,40) = 0.2667, p= 0.6084, Figure 2E). Similarly, the efficacy of
BBNPPI, which is also used to assess normal temporal processing
(Turner et al., 2006; Turner and Parrish, 2008; Middleton et al.,
2011; Llano et al., 2012), was identical inWT andmutant animals
both before and after the administration of salicylate (two-
way ANOVA, Genotype Factor: F(1,46) = 0.4673, p = 0.4976;
Treatment Factor: F(1,46) = 0.009994, p = 0.9208, Figure 2F).
These control experiments confirmed that BBN PPIAS and
GPIAS are not affected by salicylate in bothWT andKOmice and
support the notion that salicylate causes greater gap detection
deficits at 32 kHz in GLAST KO than it does in WT mice.
We also assessed how basal startle amplitudes were affected
in WT and GLAST KO mice by salicylate. Salicylate treatment
increased the startle amplitude in response to startle pulses alone
in KOmice (two-way ANOVA, Genotype Factor: F(1,56) = 37.90,
p < 0.0001; Treatment Factor: F(1,56) = 17.86, p < 0.0001,
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FIGURE 3 | GLAST deficiency sensitizes mice to salicylate-induced hearing loss but without affecting outer hair cell function. (A) GLAST KO mice
subjected to startle pulses showed significantly larger startle responses than did WT mice. Salicylate (black, SS) enhanced the startle reflexes of GLAST KO mice.
Pre-treatment values are shown in white. Data represent means ± SEM (n = 8–14). Auditory threshold shifts (B) and distortion-product otoacoustic emissions
(DPOAEs C) of GLAST WT (white circles) and homozygous (black diamonds) mice with sodium salicylate at 300 mg/kg/day for 3 days, measured 2 h after the last
injection. The uppermost curve (in gray) represents the mean for saline-treated WT control animals analyzed on the same day. Data of the auditory measures
represent means ± SEM (n = 10–16). ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 and ∗∗∗∗P < 0.0001, by a two-way ANOVA with post hoc Bonferroni test.
Figure 3A). Changes in hearing thresholds could account for
differences in gap detection as well as in PPI. It is worth
noting that salicylate caused a loss of hearing threshold by
20 dB across all frequencies (from 8 to 32 kHz) in WT
mice and 35 dB in GLAST KO mice (two-way ANOVA,
Genotype Factor, F(1,57) = 35.03, p < 0.0001; Frequency Factor,
F(2,57) = 0.8140, p = 0.4482, n = 10–16, Figure 3B) with
distortion-product otoacoustic emissions (DPOAEs) reduced by
half, and in a similar way in WT and KOmice (Genotype Factor,
F(16,340) = 19.05, p= 0.9188; Frequency Factor, F(16,340) = 1.248,
p < 0.0001, Figure 3C). However, DPOAE measures were only
performed at suprathreshold levels, and potential differences
at threshold could have occurred. Still, the lack of differences
in DPOAEs between WT and KO mice suggests that GLAST
does not regulate outer hair cell function; rather GLAST could
potentiate the effects of salicylate at the afferent synapse as
suggested by the greater threshold shifts in GLAST KO mice.
These findings are in agreement with previous work showing
that salicylate potentiates glutamate-evoked responses in spiral
ganglion neurons ex vivo (Ruel et al., 2008).
Such differences in salicylate-induced threshold shifts
betweenWT and KO should have equally affected the perception
of the pre-pulse or the perception of the gap and subsequent
PPIAS and GPIAS. However, the findings indicate that this
is not the case since PPI remained completely unaffected by
salicylate treatment at 32 kHz where gap detection deficits
were the greatest (Figures 2B,D). Second, we observed gap
sensing deficits in GLAST WT and KO mice at 32 kHz but
not when using a BBN as a carrier (Figure 2E), although
similar hearing threshold shifts have been found across
all frequencies tested (Figure 3B). Overall, our results
suggest that the gap detection deficits observed here are
reminiscent of tinnitus perception in the high-frequency
area and are not due to hearing loss or defective temporal
processing.
DISCUSSION
The present study shows that suppression of the startle response
in the presence of a gap can be improved in C57BL/6 and
129sv mice by shortening the ISI and that constitutive loss of
glutamate transporter function likely exacerbates the tinnitus-
inducing effects of salicylate.
In some strains of mice, the efficacy of the startle suppression
by the gap requires shorter ISI than with PPI. With a 15-ms ISI,
gap detection suppressed the startle response by nearly 80% in
C57BL/6 mice. Our findings contrast with those in the previous
studies in rats by Ison and Bowen (2000), in which a biphasic
response in the ability of the gap to suppress the startle was
observed when varying the ISI . It is likely that these differences
are related to species differences. Our results also underline the
importance of the genetic background when performing GPIAS
experiments. Previous studies have shown that PPI is highly
influenced by genetic background and that the C57BL/6 strain
displays rather efficient abilities to suppress the startle response
in the presence of a pre-pulse (Willott et al., 2003). It would thus
be interesting to evaluate howGPIAS is affected by varying ISIs in
humans and how genetic background (e.g., different ethnicities)
affects the efficacy of GPIAS.
In spite of the successful use of gap detection to identify
physiological and molecular pathways involved in tinnitus
(Engineer et al., 2011; Li et al., 2013, 2015; Kalappa et al.,
2014, 2015), there has been a lot of debate regarding the use
of gap detection for tinnitus evaluation (Campolo et al., 2013;
Fournier and Hébert, 2013; Boyen et al., 2015; Galazyuk and
Hébert, 2015). First, the low level of startle suppression in the
presence of a gap reported in tinnitus studies that have used
CBA mice leaves little margin to identify gap detection deficits
and infer the presence of tinnitus (Longenecker and Galazyuk,
2011; Hickox and Liberman, 2014; Longenecker et al., 2014).
Methods to discriminate between tinnitus and non-tinnitus
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animals have proven useful (Li et al., 2013, 2015) but an increase
in the basal suppression level of the startle response offers
a greater dynamic range for identifying tinnitus with greater
confidence. Second, Hickox and Liberman (2014) performed a
tinnitus study in which they adjusted the gap such that some
of the trials were done with a gap closer to the startle stimulus
(ISI = 0 ms) and some were done with a gap presented at
greater lead times (ISI = 70 ms). Consistent with our findings
(Figure 1), differences in gap detection between the two ISI
conditions were found (being less efficient with greater lead
times), however the authors interpreted that tinnitus ‘‘was not
filling’’ the gap, since deficits in GPIAS were not observed
at both ISIs (Hickox and Liberman, 2014). We believe the
experimental conditions used were not optimal for inferring
the presence of tinnitus as they used CBA mice, whose basal
level of startle suppression in the presence of the gap was
inefficient and even more variable with greater ISI. In addition,
it has been shown that scopolamine, a muscarinic receptor
blocker that disrupts cholinergic function in the brain, affects
gap detection when the ISI is larger and not when the gap is
closer to the startle stimulus (Ison and Bowen, 2000), meaning
that different mechanisms operate GPIAS depending on the
ISI. As a consequence, since GPIAS is a reflex response that
relies on temporal processing and not on a conscious percept
(meaning tinnitus does not fill the gap but interferes with
the reflex response per se), gap detection deficits caused by
tinnitus cannot be expected to be equally efficient at various
lead times. The mechanism with which salicylate interferes solely
with GPIAS and not PPI is not well understood, however it
has been shown that gap detection operates in the auditory
cortex, which is not the case of PPI (Bowen et al., 2003).
Recent optogenetic studies in mice have shown that cortical
inhibition is important in controlling perceptual gap detection
(Weible et al., 2014). Since salicylate has been shown to alter
the activity in the auditory cortex (Wang et al., 2006; Sun
et al., 2009), we postulate that salicylate alters perceptual
gap detection at the level of the auditory cortex. Additional
behavioral methods in mice would be needed to confirm that
the GPIAS deficits observed here correlate with a tinnitus
percept.
Previous studies have shown that the ability to suppress the
startle response in the presence of a gap improves with experience
or with repeated pre-acclimatization sessions (Crofton et al.,
1990; Ison and Bowen, 2000), and can reach 50% of startle
suppression in CBA mice (Ison et al., 2002). The same applies
to PPI (Plappert et al., 2006). We believe that the CBA
strain, which is commonly used in the auditory field because
of the well-preserved hearing, is not appropriate for PPIAS
and GPIAS studies, unless longer acclimatization sessions are
performed to achieve efficient gap processing. Instead, C57BL/6
or C57BL/6 × 129sv mixed mice (typical of most mouse mutant
models available) would be most appropriate at an age when
PPIAS/GPIAS responses are maximized and hearing deficits not
yet detectable (between 3 and 4 months of age). Longenecker
and Galazyuk (2012) also improved gap detection by decreasing
the startle stimulus intensity to non-saturating levels (around
105 dB SPL), which has not been implemented in the current
experiment. The differences we observe may also be due to
differences in sound quality. With the exception of the initial
study by Turner and Parrish (2008); Hickox and Liberman
(2014), who describe a 48 dB/octave roll-off in their sound
filtering like the one used in the present report, none of the other
studies that used GPIAS describe the frequency filtering slope
of their narrowband noises. Typically, when the shape of the
filter is too narrow (e.g., when the slope of the filter is steep),
perceptual artifacts are generated and could interfere with the
ability of tinnitus to disrupt GPIAS. These artifacts decrease
when using a 48 dB/octave roll-off, and could contribute to
improved ‘‘detectability’’ of tinnitus. How the contour of the
narrowband filtering affects the ability of tinnitus to interfere
with GPIAS remains to be addressed. We believe that the
appropriate selection of background strain, startle impulse level
and ISI can provide robust PPI and gap detection responses
when combined with adequate acclimatization sessions. Such
parameters should be taken into account when testing gap
detection for the assessment of tinnitus in humans.
The identification of GPIAS deficits in the 32-kHz frequency
region when using salicylate in GLAST KO mice contrasts with
previous research. A recent review article by Galazyuk and
Hébert (2015) summarizes the results obtained with different
tinnitus models using GPIAS. It appears that the generation of
tinnitus by salicylate varies in terms of frequency depending on
species and strains (i.e., Wistar rats get broader-range tinnitus,
Brown Norways display tinnitus at 10, 12 and 24 kHz, and
Sprague Dawleys at 16 kHz). The overall conclusion is that
tinnitus does not seem to be focal and its frequency depends
on the strain used. It is possible that we may have missed some
frequencies in our screening that would have been otherwise
revealed using lower carrier sound intensities and a greater
number of animals throughout the procedure. Conversely, the
protocols using GPIAS to assess tinnitus are very diverse and
none of the salicylate studies (with the exception of the article
by Turner and Parrish, 2008) have tested potential GPIAS
deficits at 32 kHz (Galazyuk and Hébert, 2015). It is thus hard
to determine whether our findings are specific to our model,
or whether salicylate-induced tinnitus typically triggers high-
frequency tinnitus, or simply whether the deficits in GPIAS
are truly triggered by tinnitus per se and do not result from
confounding effects of hearing loss. The control experiments we
have performed rule out the potential bias of high-frequency
hearing loss in the disrupted GPIAS observed in GLASTKOmice
since: (i) auditory thresholds were equally affected by salicylate in
WT and KO mice at all frequencies; (ii) salicylate did not affect
GPIAS using a BBN carrier sound; (iii) basal auditory thresholds
were normal and equivalent in bothWT and KOmice at the time
of the test; and (iv) salicylate treatment did not disrupt PPI in
either WT or KO mice at 32 khZ, which otherwise would have
been altered if hearing loss had contributed to the lower GPIAS
at 32 kHz found in GLAST KO mice treated with salicylate.
However, we do not rule out the possibility that in spite of the
significant changes in GPIAS (in either genotype), the lack of
changes in PPI upon salicylate administration could arise from
salicylate-induced loudness recruitment, which may maintain
suprathreshold PPI behavior.
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Our study proposes the first gene potentially involved in
tinnitus. GLASTs are mainly present in astrocytes in the central
nervous system, buffering the excess of glutamate released at
the synaptic cleft, converting it into glutamine, which is then
transported back to pre-synaptic terminals to be recycled to
glutamate. Two major glutamate transporters, namely GLAST
(predominant in the cortex and hippocampus) and the glial
GLutamate Transporter GLT1 (predominant in the cerebellum),
are responsible for more than 80% of the glutamate uptake
in the brain. Loss of glutamate transporters with subsequently
uncontrolled extracellular glutamate levels has been associated
with neurotoxic effects during seizures, amyotrophic lateral
sclerosis, epilepsy and now, possibly, tinnitus. Although species
comparison in gene expression levels is difficult to evaluate,
given the broad changes in endogenous normalizing components
(e.g., ubiquitously expressed genes), it appears likely that the
resistance of mice to auditory insults could result, at least
in part, from the higher expression of cochlear GLAST. On
the other hand, a low abundance of cochlear GLAST would
predict higher sensitivity to noise and drug-induced tinnitus.
Consistent with this notion, we found that GLAST mRNA
abundance was greater in CBA mouse cochleae than in those
from CD-1 mice (CBA: 1.02 ± 0.06 relative expression level;
CD-1: 0.76 ± 0.04; p = 0.008 by an unpaired two-tailed t-test,
n = 5 per strain), which correlates with these strains’ known
auditory sensitivity and development of age-related hearing loss.
In this regard, Shimizu et al. (2005) found that GLAST KO
mice are more vulnerable to kanamycin ototoxicity. Ongoing
data collection in our laboratory indicates that this is also
the case for cisplatin (unpublished observations). In humans,
whose susceptibility to ototoxic medications and noise varies
from one individual to another, it remains unknown how
cochlear GLAST levels correlate with tinnitus predisposition.
A recent study failed to detect GLAST protein in support
cells from the human cochlea (Ahmed et al., 2013), suggesting
that the human cochlea expresses very low levels in GLAST
at the afferent synapse. As a consequence, we predict that
humans would show less glutamate-buffering capacity and thus
greater vulnerability to noise and ototoxic medications. Genetic
analyses of the human homolog of GLAST (EAAT1) in subjects
with and without tinnitus could bring new knowledge about
the mechanisms underlying the vulnerability and resilience to
tinnitus.
It is rather widely accepted that peripherally generated
tinnitus arises from a lack of cochlear output, rather than an
increase in cochlear output. There are clear cochlear differences
between salicylate and noise insults whereby spontaneous activity
of the auditory nerve (AN) is increased after salicylate but
decreased after noise (Eggermont and Roberts, 2004). However,
most measures in noise-traumatized animals are performed
after noise exposure and not during noise exposure. Thus, we
would predict an early phase of increased AN activity during
noise exposure (Searchfield et al., 2004) and a decrease in AN
activity resulting from permanent synaptic damage. In contrast
to noise, measures on salicylate-treated animals are performed
shortly after the administration of salicylate—presumably when
salicylate bioavailability peaks in the cochlea. Although there are
to our knowledge no studies that report salicylate bioavailability
in the cochlea after intraperitoneal injections, a peak is observed
in other tissues after 30–60 min, with blood clearance after 8 h
(Sturman et al., 1968). As salicylate potentiates glutamate-evoked
responses in primary afferent neurons (Ruel et al., 2008), and
lack of GLAST results in increased excess glutamate at the IHC-
cochlear nerve synapse (Hakuba et al., 2000; Glowatzki et al.,
2006), the overall cochlear output in GLAST KO mice would
be expected to increase before salicylate is cleared out. Whether
repeated administration of salicylate would cause permanent
damage is unclear, but a recent rat model of chronic salicylate-
administration leads tinnitus (Yi et al., 2016) and could prove
useful to investigate whether more permanent damages would
occur at the synapse, and reconcile salicylate-induced tinnitus
with the decreased cochlear output theory.
The tinnitus effects observed here could also underlie central
actions of salicylate and/or loss of GLAST function in the
brain. Indeed, systemic administration of salicylate could activate
non-auditory structures (Stolzberg et al., 2012; Chen et al.,
2015) translating into broader central impacts than those
happening after noise exposure (Holt et al., 2010). However,
GLAST is predominant in the cortex and the hippocampus,
and whether it is present in structures of the auditory pathway
is unknown. The higher baseline startle amplitudes observed
in GLAST KO mice could reflect hyperacusis. These findings
are also consistent with the known higher anxiety levels in
this model (Karlsson et al., 2009): increased locomotor activity
in the open field, decreased sociability and social novelty
preference, and poor nesting behavior. In addition, (Karlsson
et al., 2009) found that pairwise discrimination learning is
also affected in GLAST KO mice. The startle responses
we obtain are however inconsistent with Karlsson et al.’s
(2009) findings, which were not controlled—as we did with
ABR—for hearing levels (as acknowledged by the authors),
known to be affected at 6 months of age in GLAST KO
mice (Hakuba et al., 2000). Importantly, unlike the auditory
field, which uses startle response as an indicator of hearing
abilities, all biological psychiatry textbooks mention the use
of the startle response as a gauge of fear or anxiety. For
instance, people with post-traumatic stress disorder have greater
startle responses (Grillon et al., 1998). After an animal has
learned to associate a specific stimulus with fear, such as light
being paired with shocks, greater startle response is observed
after presenting a fear signal just before the startle stimulus.
Conversely, signals associated with pleasure decrease the startle
amplitude response (Schmid et al., 1995). Fear or pleasure
signals fail to modulate the startle response in amygdala-lesioned
animals, showing that the amygdala is involved in the startle
response system (Hitchcock and Davis, 1991). We thus believe
that the increased startle response seen in GLAST KO mice
in the presence of salicylate is an indicator of amygdala-
mediated effects. The recent evidence linking tinnitus with
the amygdala suggests that central-GLAST deficiency in the
amygdala could contribute to the increased tinnitus severity
observed in GLAST KO mice. Nonetheless, Karlsson et al.
(2009) also found that PPI was not affected in GLAST KO
mice and hence reasoned that these mice display some of the
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multiple and complex symptoms belonging to schizophrenia
(e.g., GLAST KO mice would belong to a subgroup of
schizophrenia of lesser severity). Salicylate, which is known to
be anxiogenic in high doses (Puel and Guitton, 2007; Guitton,
2009), exacerbated this anxiety effect by increasing startle
amplitude responses in KO animals (Figure 3A), something
that we were able to qualitatively observe when handling
the animals. It is thus possible that the higher basal anxiety
levels of GLAST KO mice facilitated the tinnitus-inducing
effects of salicylate, thereby increasing tinnitus intensity. Specific
deletion of GLAST either in the brain or in the ear should
enable discrimination of the contribution of all of these
factors.
CONCLUSION
Our results suggest a potential role for GLAST in the
vulnerability to salicylate-induced tinnitus. Given the magnitude
of the disruption in gap detection observed in GLAST KO
mice treated with salicylate, we propose that GLAST deficiency
may serve as a useful model to distinguish more subtle, yet
unidentified mechanisms on how tinnitus is triggered and
maintained. Finally, optimizing parameters in gap detection in
humans may uncover a potential use of this technology in the
objective diagnosis of tinnitus (Galazyuk and Hébert, 2015).
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